Abt Associates: Bold thinkers driving real-world impact
Two years ago Abt Associates partnered with the global community to address preventable deaths due to diarrhea and pneumonia as a signatory to the Declaration on Scaling Up Treatment of Diarrhea and Pneumonia.
The Abt-led Strengthening Health Outcomes through the Private Sector (SHOPS) project continued Abt’s support of this effort by hosting the UN Commission on Lifesaving MCH Commodities Diarrhea and Pneumonia Working Group (DPWG) quarterly meeting in Abt’s Bethesda office on May 8-9. More than 46 people attended representing 40 partner organizations, including USAID, UNICEF, PATH, the Bill & Melinda Gates Foundation, and the Clinton Health Access Initiative.
The DPWG is a global coordinating body of representatives from development agencies, donors, NGOs, and the private sector who are active in diarrhea and pneumonia treatment scale-up activities. The DPWG is focused on 10 high-burden countries that account for more than 60 percent of global diarrhea and pneumonia cases: Bangladesh, Democratic Republic of the Congo, Ethiopia, Kenya, India, Niger, Nigeria, Pakistan, Tanzania, and Uganda. The DPWG is working to achieve treatment coverage of 60 percent to 80 percent by 2015 for children under five.
Abt Associates is a mission-driven, global leader in research, evaluation and program implementation in the fields of health, social and environmental policy, and international development. Known for its rigorous approach to solving complex challenges, Abt Associates is regularly ranked as one of the top 20 global research firms and one of the top 40 international development innovators. The company has multiple offices in the U.S. and program offices in more than 40 countries.